---
figid: PMC5900789__fimmu-09-00682-g001
figlink: /pmc/articles/PMC5900789/figure/F1/
number: Figure 1
caption: IL-10-mediated modulation of myeloid cells. IL-10 binds to a tetrameric receptor
  consisting of two IL-10Rα and two IL-10Rβ subunits. 1. IL-10/IL-10R interaction
  leads to JAK1 and TYK2 phosphorylation and the consequent STAT3 and STAT1 phosphorylation.
  P-STATs, and in particular P-STAT3, dimerizes and translocates to the nucleus, where
  it promotes the transcription of specific molecules (i.e., SOCS3) or transcription
  factors (i.e., BCL3 and NFIL3), and inhibits the transport of MHC class II to the
  plasma membrane. 2. IL-10 signaling inhibits LPS-mediated activation of IKK that
  in turn prevents NF-kB-p65/p50 nuclear translocation and the expression of pro-inflammatory
  cytokine. In parallel, IL-10 promotes the selective NF-kB-p50/p50 nuclear translocation,
  which concurs in downregulating pro-inflammatory cytokine expression, and, in association
  with BCL3, promotes IL-10 expression. 3. IL-10 inhibits PI3K/Akt pathway that prevents
  LPS-mediated activation of MyD88, resulting in the inhibition of the expression
  of IRF-3 and IRF-8. 4. IL-10-mediated inhibition of PI3K/Akt pathway leads to GSK3β
  and MITF activation, responsible for the upregulation of the transcription of GPNMB.
  5. IL-10 downmodulates LPS-induced expression of miR155, which directly inhibits
  SHIP1 and favors the negative regulation of TLR4 signaling by counteracting PI3K
  activity. 6. IL-10 enhances LPS-mediated induction of miR146b and miR187, which
  post-transcriptionally regulate mRNA encoding for TNF-α and reduce IL-6 and IL-12p40
  transcription via inhibition of the transcription factor IkB. TYK, tyrosine kinase;
  JAK, Janus kinase; PI3K, phosphoinositide 3-kinase; Akt, protein kinase B; MyD88,
  myeloid differentiation primary response 88; STAT, signal transducer and activator
  of transcription; IKK, IkB kinase; NF-kB, nuclear factor kappa-light-chain-enhancer
  of activated B cells; GSK3β, glycogen synthase kinase 3 beta; MITF, microphthalmia-associated
  transcription factor; MAPK, mitogen-activated protein kinase; SHIP1, SH-2 containing
  inositol 5′ polyphosphatase 1; Bcl3, B-cell lymphoma 3-encoded protein; NFIL3, nuclear
  factor interleukin 3; TFs, unknown transcription factors; SOCS, suppressor of cytokine
  signaling; GPNMB, glycoprotein NMB; HO-1, heme-oxygenase-1; ILT, immunoglobulin-like
  transcript; IRF, interferon regulatory factor; IL-10R, IL-10 receptor.
pmcid: PMC5900789
papertitle: Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via
  Antigen-Specific T Regulatory Type 1 Cells.
reftext: Michela Comi, et al. Front Immunol. 2018;9:682.
pmc_ranked_result_index: '79805'
pathway_score: 0.9599326
filename: fimmu-09-00682-g001.jpg
figtitle: IL-10-mediated modulation of myeloid cells
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5900789__fimmu-09-00682-g001.html
  '@type': Dataset
  description: IL-10-mediated modulation of myeloid cells. IL-10 binds to a tetrameric
    receptor consisting of two IL-10Rα and two IL-10Rβ subunits. 1. IL-10/IL-10R interaction
    leads to JAK1 and TYK2 phosphorylation and the consequent STAT3 and STAT1 phosphorylation.
    P-STATs, and in particular P-STAT3, dimerizes and translocates to the nucleus,
    where it promotes the transcription of specific molecules (i.e., SOCS3) or transcription
    factors (i.e., BCL3 and NFIL3), and inhibits the transport of MHC class II to
    the plasma membrane. 2. IL-10 signaling inhibits LPS-mediated activation of IKK
    that in turn prevents NF-kB-p65/p50 nuclear translocation and the expression of
    pro-inflammatory cytokine. In parallel, IL-10 promotes the selective NF-kB-p50/p50
    nuclear translocation, which concurs in downregulating pro-inflammatory cytokine
    expression, and, in association with BCL3, promotes IL-10 expression. 3. IL-10
    inhibits PI3K/Akt pathway that prevents LPS-mediated activation of MyD88, resulting
    in the inhibition of the expression of IRF-3 and IRF-8. 4. IL-10-mediated inhibition
    of PI3K/Akt pathway leads to GSK3β and MITF activation, responsible for the upregulation
    of the transcription of GPNMB. 5. IL-10 downmodulates LPS-induced expression of
    miR155, which directly inhibits SHIP1 and favors the negative regulation of TLR4
    signaling by counteracting PI3K activity. 6. IL-10 enhances LPS-mediated induction
    of miR146b and miR187, which post-transcriptionally regulate mRNA encoding for
    TNF-α and reduce IL-6 and IL-12p40 transcription via inhibition of the transcription
    factor IkB. TYK, tyrosine kinase; JAK, Janus kinase; PI3K, phosphoinositide 3-kinase;
    Akt, protein kinase B; MyD88, myeloid differentiation primary response 88; STAT,
    signal transducer and activator of transcription; IKK, IkB kinase; NF-kB, nuclear
    factor kappa-light-chain-enhancer of activated B cells; GSK3β, glycogen synthase
    kinase 3 beta; MITF, microphthalmia-associated transcription factor; MAPK, mitogen-activated
    protein kinase; SHIP1, SH-2 containing inositol 5′ polyphosphatase 1; Bcl3, B-cell
    lymphoma 3-encoded protein; NFIL3, nuclear factor interleukin 3; TFs, unknown
    transcription factors; SOCS, suppressor of cytokine signaling; GPNMB, glycoprotein
    NMB; HO-1, heme-oxygenase-1; ILT, immunoglobulin-like transcript; IRF, interferon
    regulatory factor; IL-10R, IL-10 receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL10RB
  - IL6
  - GPNMB
  - HLA-G
  - CD86
  - MAPK8
  - MAPK11
  - MAPK9
  - CD80
  - CD14
  - BCL3
  - PIK3R3
  - PIK3R6
  - HMOX1
  - IKBKB
  - CHUK
  - MAPK1
  - MAPK3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - AKT2
  - PIK3CG
  - AKT1
  - AKT3
  - IRF8
  - JAK1
  - INPP5D
  - SOCS3
  - STAT1
  - IKBKG
  - IL10
  - IL10RA
  - TNF
  - TYK2
  - LILRB4
  - LILRB2
  - IRF3
  - MITF
  - MYD88
  - IRF6
  - MAPK13
  - MAPK14
  - PIK3R5
  - PIK3R4
  - TF
  - TLR4
  - NFKB1
  - MAPK10
  - MAPK12
  - STAT3
  - NFIL3
  - LPS
genes:
- word: IL-10RB
  symbol: IL10RB
  source: hgnc_symbol
  hgnc_symbol: IL10RB
  entrez: '3588'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: GPNMB
  symbol: GPNMB
  source: hgnc_symbol
  hgnc_symbol: GPNMB
  entrez: '10457'
- word: HLA-G
  symbol: HLA-G
  source: hgnc_symbol
  hgnc_symbol: HLA-G
  entrez: '3135'
- word: CD86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: CD80
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: CD14
  symbol: CD14
  source: hgnc_symbol
  hgnc_symbol: CD14
  entrez: '929'
- word: Bcl3
  symbol: BCL3
  source: hgnc_symbol
  hgnc_symbol: BCL3
  entrez: '602'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: HO-1
  symbol: HO-1
  source: hgnc_alias_symbol
  hgnc_symbol: HMOX1
  entrez: '3162'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IRF-8
  symbol: IRF-8
  source: hgnc_alias_symbol
  hgnc_symbol: IRF8
  entrez: '3394'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: SHIP
  symbol: SHIP
  source: hgnc_alias_symbol
  hgnc_symbol: INPP5D
  entrez: '3635'
- word: SOCS3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: STAT-1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IL-10
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: IL-10Ra
  symbol: IL10RA
  source: hgnc_symbol
  hgnc_symbol: IL10RA
  entrez: '3587'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: ILT-3
  symbol: ILT3
  source: hgnc_alias_symbol
  hgnc_symbol: LILRB4
  entrez: '11006'
- word: ILT-4
  symbol: ILT4
  source: hgnc_alias_symbol
  hgnc_symbol: LILRB2
  entrez: '10288'
- word: IRF-3
  symbol: IRF3
  source: hgnc_symbol
  hgnc_symbol: IRF3
  entrez: '3661'
- word: MITF
  symbol: MITF
  source: hgnc_symbol
  hgnc_symbol: MITF
  entrez: '4286'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: ?TFs
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: NF-kB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: STAT-3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: NFIL3
  symbol: NFIL3
  source: hgnc_symbol
  hgnc_symbol: NFIL3
  entrez: '4783'
chemicals: []
diseases:
- word: LPS
  source: MESH
  identifier: C536528
---
